Pfizer and BioNTech are sending the first Covid-19 vaccine to the FDA today
The first Covid-19 vaccine is heading to regulators.
Pfizer and BioNTech announced Friday morning that they would ask today for the FDA to issue an emergency use authorization for their Covid-19 candidate.
The submission, a major milestone in the fight against the pandemic and in history’s most intensive and closely-watched drug development race, will put the ball in the agency’s court, where regulators will pour over all the data the companies have generated since winter and solicit recommendations from outside advisors before making a decision.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 94,300+ biopharma pros reading Endpoints daily — and it's free.